Wednesday, October 16, 2019 8:15:36 AM
MediPharm Labs (OTCQX:MEDIF) has signed a private label cannabis concentrate supply agreement with Ontario-based cannabis-infused tea and edibles manufacturer, Olli Brands.
Under the 18-month supply agreement, MediPharm will provide cannabis distillate and crude to Olli upon its commercial licensing.
Olli will utilize MediPharm’s products to infuse its line of curated edibles. Olli currently holds a research licence under the Cannabis Act and is awaiting final approval for its standard processing licence prior to commercializing its line of edible and tea-based products.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM